This is happening this time and it is the most amazing feeling.
The COC is a new process for British Standards Institute as they moved their office to the Netherlands to give the European CE Mark approval.
My guess is the 3 people on the COC weren't experts in pancreatic cancer or radiation therapy so they needed to see a much deeper analysis.
OncoSil submitted a literature review of 4,000 studies and also had more data read out on the study that BSI originally asked them to do from last year. The company put a summary of this in the AGM presentation last month and it was very impressive for me.
This has now met the requirements for approval and it is now a formality.
Those suffering from the insidious disease of pancreatic cancer will soon have an extra option on top of the chemo they receive.
Great news people.
This is happening this time and it is the most amazing...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.58M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $102 | 20.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 27827650 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29345097 | 22 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.5¢ | 0.4¢ | 129546 | ||
| Last updated 11.53am 17/05/2024 ? | |||||
| OSL (ASX) Chart |